As of 2025-10-23, the EV/EBITDA ratio of Global Blood Therapeutics Inc (GBT) is -16.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GBT's latest enterprise value is 4,942.22 mil USD. GBT's TTM EBITDA according to its financial statements is -293.25 mil USD. Dividing these 2 quantities gives us the above GBT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 13.5x | 10.6x |
| Forward P/E multiples | 10.5x - 22.5x | 13.8x |
| Fair Price | (50.56) - (63.60) | (57.99) |
| Upside | -173.8% - -192.9% | -184.7% |
| Date | EV/EBITDA |